- Generic name
- Linagliptin + Metformin Hydrochloride
- Strength
- 2.5 mg + 500 mg
- Dosage form
- Tablet
- Manufactured by
- Albion Laboratories Ltd.
Renaliv Met 2.5/500 Tablet
About Renaliv Met 2.5/500 Tablet
Renaliv Met 2.5/500 is a tablet from Albion Laboratories Ltd., with the generic name Linagliptin + Metformin Hydrochloride. It is chosen when treatment with both linagliptin and metformin hydrochloride together is suitable for the person.
There are 31 brands of Linagliptin + Metformin Hydrochloride listed in Bangladesh. The lowest listed price is Linatin M 2.5 mg + 500 mg Tablet at ৳ 7.00 per unit.
What is Renaliv Met 2.5/500 Tablet?
The tablet Renaliv Met 2.5/500 contains Linagliptin + Metformin Hydrochloride and is made by Albion Laboratories Ltd. Metformin is a biguanide that helps control blood glucose levels. The tablet is available in the strength 2.5 mg + 500 mg. Whether it suits you is a decision for your doctor.
Uses of Renaliv Met 2.5/500
It is chosen when treatment with both linagliptin and metformin hydrochloride together is suitable for the person. It is added to a proper diet and exercise plan to improve blood sugar control when treatment with both linagliptin and metformin is considered appropriate. Your doctor will assess whether this combination is right for you.
How to use Renaliv Met 2.5/500
Swallow the tablet with meals as directed. Swallow the tablet with water. Renaliv Met 2.5/500 is taken by mouth. Take Renaliv Met 2.5/500 2.5 mg + 500 mg tablet exactly as prescribed by your doctor. The doctor decides the dose and course, including any gradual change in dose to reduce stomach upset linked to metformin. The dose and course are set by the doctor for each person, so follow the instructions given to you and do not change them yourself.
Side effects of Renaliv Met 2.5/500
Your doctor can advise on what to watch for. Low blood sugar (hypoglycemia) is more common when this medicine is used together with sulfonylureas. Some people may have other reactions. Tell your doctor if any side effect bothers you or does not go away. Contact your doctor if you notice anything unusual after taking it.
Safety and precautions
It should be used in pregnancy only if clearly needed, and caution is advised during breastfeeding. Do not start or stop this medicine without medical advice. It is contraindicated in people with renal impairment, in acute or chronic metabolic acidosis such as diabetic ketoacidosis, and in anyone hypersensitive to linagliptin or metformin. Tell your doctor about all the other medicines you take.
Frequently asked questions
What is Renaliv Met 2.5/500 used for?
It is chosen when treatment with both linagliptin and metformin hydrochloride together is suitable for the person. It is added to a proper diet and exercise plan to improve blood sugar control when treatment with both linagliptin and metformin is considered appropriate.
How do I use Renaliv Met 2.5/500 correctly?
Swallow the tablet with meals as directed. Swallow the tablet with water.
Can Renaliv Met 2.5/500 cause side effects?
Your doctor can advise on what to watch for. Low blood sugar (hypoglycemia) is more common when this medicine is used together with sulfonylureas.
Who should be careful with Renaliv Met 2.5/500?
It should be used in pregnancy only if clearly needed, and caution is advised during breastfeeding. Do not start or stop this medicine without medical advice.
Indications
Pharmacology
Metformin Hydrochloride is a biguanide type oral antihyperglycemic drug used in the management of type 2 diabetes. It lowers both basal and postprandial plasma glucose. Its mechanism of action is different from those of sulfonylureas and it does not produce hypoglycemia. Metformin Hydrochloride decreases hepatic glucose production, decreases intestinal absorption of glucose and improves insulin sensitivity by an increase in peripheral glucose uptake and utilization.
Dosage & Administration
Recommended starting dose: In patients currently not treated with Metformin Hydrochloride, initiate treatment with 2.5 mg Linagliptin and 500 mg Metformin Hydrochloride twice daily.
In patients already treated with Metformin Hydrochloride, start with 2.5 mg Linagliptin and the current dose of Metformin Hydrochloride twice daily.
Patients already treated with Linagliptin and Metformin Hydrochloride, individual components may be switched to this combination containing the same doses of each component.
Linagliptin & Metformin extend release tablet: The dosage of this combination should be individualized on the basis of both effectiveness and tolerability, while not exceeding the maximum recommended total daily dose of Linagliptin 5 mg and Metformin Hydrochloride 2000 mg. this combination should be given once daily with a meal.
Recommended starting dose: In patients currently not treated with metformin, initiate this combination treatment with 5 mg Linagliptin/1000 mg Metformin Hydrochloride extended-release once daily with a meal.
In patients already treated with Metformin, start this combination with 5 mg of Linagliptin total daily dose and a similar total daily dose of Metformin once daily with a meal.
In patients already treated with Linagliptin & Metformin immediate release tablet, switch to extend release tablet containing 5 mg of Linagliptin total daily dose and a similar total daily dose of Metformin once daily with a meal.
5 mg Linagliptin & 1000 mg Metformin Hydrochloride extended-release tablet should be taken as a single tablet once daily. Patients using 2.5 mg Linagliptin & 1000 mg Metformin extended release tablets should take two tablets together once daily.
Interaction
P-glycoprotien/CYP3A4 inducer (i.e. rifampin): The efficacy of this medicine may be reduced when administered in combination.
Contraindications
Side Effects
Pregnancy & Lactation
Precautions & Warnings
Overdose Effects
During controlled clinical trials in healthy subjects, with single doses of up to 600 mg of Linagliptin (equivalent to 120 times the recommended daily dose), there were no dose-related clinical adverse drug reactions.
Overdose of Metformin Hydrochloride has occurred in case of ingestion of amounts greater than 50 grams. Hypoglycemia was reported in approximately 10% of cases, but no causal association with Metformin Hydrochloride has been established. Lactic acidosis has been reported in approximately 32% of Metformin Hydrochloride overdose cases.
Storage Conditions
Alternative brands of Linagliptin + Metformin Hydrochloride
Other brands with the same generic name, cheapest first.
Linatin M Tablet
2.5 mg + 500 mg
Linagliptin + Metformin Hydrochloride
Delta Pharma Limited
৳ 6.86 ৳ 7.00 2% off per unit
Linatin M Tablet
2.5 mg + 850 mg
Linagliptin + Metformin Hydrochloride
Delta Pharma Limited
৳ 7.84 ৳ 8.00 2% off per unit
Adlinameg Tablet
2.5 mg+500 mg
Linagliptin + Metformin Hydrochloride
UniMed UniHealth
৳ 11.76 ৳ 12.00 2% off per unit
Formet-L Tablet
2.5 mg + 500 mg
Linagliptin + Metformin Hydrochloride
Biopharma Ltd.
৳ 11.76 ৳ 12.00 2% off per unit
Carlina-M Tablet
2.5 mg+500 mg
Linagliptin + Metformin Hydrochloride
Radiant Pharmaceuticals Ltd.
৳ 12.74 ৳ 13.00 2% off per unit
Biolina Plus Tablet
2.5 mg+850 mg
Linagliptin + Metformin Hydrochloride
Biogen Pharmaceuticals Ltd.
৳ 13.23 ৳ 13.5 2% off per unit
Adlinameg Tablet
2.5 mg+850 mg
Linagliptin + Metformin Hydrochloride
UniMed UniHealth
৳ 13.72 ৳ 14.00 2% off per unit
Carlina-M Tablet
2.5 mg+850 mg
Linagliptin + Metformin Hydrochloride
Radiant Pharmaceuticals Ltd.
৳ 13.72 ৳ 14.00 2% off per unit
Carlina-M Tablet
2.5 mg+1000 mg
Linagliptin + Metformin Hydrochloride
Radiant Pharmaceuticals Ltd.
৳ 15.68 ৳ 16.00 2% off per unit
Carlina-M 2.5/1000 Tablet
2.5 mg + 1000 mg
Linagliptin + Metformin Hydrochloride
Radiant Pharmaceuticals Ltd.
৳ 15.68 ৳ 16 2% off per unit
Carlina-M 2.5/850 Tablet
2.5 mg + 850 mg
Linagliptin + Metformin Hydrochloride
Radiant Pharmaceuticals Ltd.
Price not listed
Carlina-M FC Tablet Tablet
2.5 mg + 500 mg
Linagliptin + Metformin Hydrochloride
Radiant Pharmaceuticals Ltd.
Price not listed
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.